Researcher
Wim Nerinckx
- Disciplines:Biophysics, Molecular and cell biology, Medical biochemistry and metabolism, Laboratory medicine, Microbiology, Systems biology, Plant biology, Biochemistry and metabolism, Medicinal and biomolecular chemistry
Affiliations
- Department of Biomedical molecular biology (Department)
Member
From1 Jan 2011 → 18 Jun 2014 - Department of Biochemistry and microbiology (Department)
Member
From1 Apr 1994 → Today
Publications
1 - 10 of 13
- GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery(2023)
Authors: Loes van Schie, Wander Van Breedam, Charlotte Roels, Martin Frank, Ahmadreza Mehdipour, Bram Laukens, Wim Nerinckx, Francis Santens, Simon Devos, Iebe Rossey, et al.
- Selective engagement of FcγRIV by a M2e-specific single domain antibody construct protects against influenza A virus infection(2019)
Authors: Dorien De Vlieger, Katja Hoffmann, Inge Van Molle, Wim Nerinckx, Lien Van Hoecke, Marlies Ballegeer, Sarah Creytens, Han Remaut, Hartmut Hengel, Bert Schepens, et al.
- Disruption of endocytosis through chemical inhibition of clathrin heavy chain function(2019)
Authors: Wim Dejonghe, Isha Sharma, Bram Denoo, Steven De Munck, Qing Lu, Kiril Mishev, Haydar Bulut, Evelien Mylle, Riet De Rycke, Mina Vasileva, et al.
Pages: 641 - 649 - Nonselective chemical inhibition of Sec7 domain-containing ARF GTPase exchange factors(2018)
Authors: Kiril Mishev, Qing Lu, Bram Denoo, Francois Peurois, Wim Dejonghe, Jan Hullaert, Sjef Boeren, Marine Bretou, Steven De Munck, Isha Sharma, et al.
Pages: 2573 - 2593 - Tozasertib analogues as inhibitors of necroptotic cell death(2018)
Authors: Sam Hofmans, Lars Devisscher, Sofie Martens, Dries Van Rompaey, Kenneth Goossens, Tatyana Divert, Wim Nerinckx, Nozomi Takahashi, Hans De Winter, Pieter Van der Veken, et al.
Pages: 1895 - 1920 - The inhibitor endosidin 4 targets SEC7 domain-type ARF GTPase exchange factors and interferes with subcellular trafficking in eukaryotes(2018)
Authors: Urszula Kania, Tomasz Nodzynski, Qing Lu, Glenn R. Hicks, Wim Nerinckx, Kiril Mishev, Francois Peurois, Jacqueline Cherfils, Peter Grones, Stephanie Robert, et al.
Pages: 2553 - 2572 - When PERK inhibitors turn out to be new potent RIPK1 inhibitors : critical issues on the specificity and use of GSK2606414 and GSK2656157(2017)
Authors: Diego Rojas Rivera, Tinneke Delvaeye, Ria Roelandt, Wim Nerinckx, Koen Augustyns, Peter Vandenabeele, Mathieu Bertrand
Pages: 1100 - 1110 - Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models(2012)
Authors: Linde Duprez, Sasker Grootjans, Wim Nerinckx, JB DuHadaway, Ria Roelandt, Filip Van Hauwermeiren, Claude Libert, GC Prendergast, A Degterev, J Yuan, et al.
- A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes
Authors: Petra Tiels, Ekaterina Baranova, Kathleen Piens, Charlotte De Visscher, Gwenda Pynaert, Wim Nerinckx, Jan Stout, Franck Fudalej, Simon Tännler, Steven Geysens, et al.
Pages: 1225 - 1231 - Theory and computation show that Asp463 is the catalytic proton donor in human endoplasmic reticulum alpha-(1 -> 2)-mannosidase I
Authors: David Cantu, Wim Nerinckx, Peter Reilly
Pages: 2235 - 2242
Patents
1 - 2 of 2